December 2017 Blog Posts (11)

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/tougher-fda-import-rules-are-aimed-at-putting-strict-controls-on-imports-3.jpg?w=1400 1400w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/best-practices-in-vendor-risk-and-compliance-management.jpg?w=838 838w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/fda-requirements-for-ensuring-premarketing-clinical-trial-safety-2.jpeg?w=844&h=562 844w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/the-investigational-new-drug-applications-mechanism-in-the-usa.jpg?w=866&h=650 866w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/the-increasing-role-of-the-social-media-in-healthcare-6.jpg?w=862&h=574 862w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/technical-writing-for-the-pharma-device-and-biotech-industries-3.jpg?w=690&h=660 690w,…

https://globalcompliancepaneltraining.files.wordpress.com/2017/12/quality-risk-management-in-the-fda-regulated-industry.jpg?w=874&h=490 874w,…

Export, import and trade compliance principle is a very important guiding standard for governing trade policies and ensuring compliance with the set national, regional and global trade norms. It helps to define an organization’s adherence to the export, import and trade compliance principle laid out by the government and also offers an…

A signal is described by the World Health Organization as any information that is reported on a possible or potential causal relationship between a drug and the adverse event it spawns. This relationship can be of virtually any nature, so long as it concerns the drug and the…